Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Legendre

Showing results (281-290 of 309) with videos related to

Pageof 31
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodiesR Sberro-Soussan, J Zuber, C Suberbielle-Boissel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2007
Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot studyD Anglicheau, A Loupy, C Suberbielle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 22, 2009
Donor-estimated GFR as an appropriate criterion for allocation of ECD kidneys into single or dual kidney transplantationR Snanoudj, M Rabant, M O Timsit, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2009
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodiesA Loupy, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2008
Sirolimus may reduce fertility in male renal transplant recipientsJ Zuber, D Anglicheau, C Elie, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 24, 2015
Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney RecipientsM Rabant, L Amrouche, L Morin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 23, 2009
Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective studyL Zafrani, L Truffaut, H Kreis, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 11, 2012
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantationJ Zuber, M Le Quintrec, S Krid, et al.
BMC Nephrology|March 6, 2021
Renal transplantation outcomes in obese patients: a French cohort-based studyY Foucher, M Lorent, L Albano, et al.
Clinical Pharmacology and Therapeutics|April 16, 2010
Optimization of initial tacrolimus dose using pharmacogenetic testingE Thervet, M A Loriot, S Barbier, et al.
Pageof 31

Showing results (281-290 of 309) with videos related to

Sort By:
Pageof 31
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodiesR Sberro-Soussan, J Zuber, C Suberbielle-Boissel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2007
Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot studyD Anglicheau, A Loupy, C Suberbielle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 22, 2009
Donor-estimated GFR as an appropriate criterion for allocation of ECD kidneys into single or dual kidney transplantationR Snanoudj, M Rabant, M O Timsit, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2009
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodiesA Loupy, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2008
Sirolimus may reduce fertility in male renal transplant recipientsJ Zuber, D Anglicheau, C Elie, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 24, 2015
Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney RecipientsM Rabant, L Amrouche, L Morin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 23, 2009
Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective studyL Zafrani, L Truffaut, H Kreis, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 11, 2012
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantationJ Zuber, M Le Quintrec, S Krid, et al.
BMC Nephrology|March 6, 2021
Renal transplantation outcomes in obese patients: a French cohort-based studyY Foucher, M Lorent, L Albano, et al.
Clinical Pharmacology and Therapeutics|April 16, 2010
Optimization of initial tacrolimus dose using pharmacogenetic testingE Thervet, M A Loriot, S Barbier, et al.
Pageof 31